CMS ENERGY CORP - CMS 5 5/8 03/15/2078 (CMSA) Fundamental Analysis & Valuation

NYSE:CMSA • US1258968601

Current stock price

21.4 USD
-0.15 (-0.71%)
Last:

This CMSA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CMSA Profitability Analysis

1.1 Basic Checks

  • In the past year CMSA was profitable.
  • CMSA had a positive operating cash flow in the past year.
  • In the past 5 years CMSA has always been profitable.
  • In the past 5 years CMSA always reported a positive cash flow from operatings.
CMSA Yearly Net Income VS EBIT VS OCF VS FCFCMSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • With a Return On Assets value of 2.66%, CMSA perfoms like the industry average, outperforming 57.69% of the companies in the same industry.
  • CMSA has a better Return On Equity (11.60%) than 76.92% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.74%, CMSA is in line with its industry, outperforming 46.15% of the companies in the same industry.
  • CMSA had an Average Return On Invested Capital over the past 3 years of 3.50%. This is in line with the industry average of 3.74%.
  • The 3 year average ROIC (3.50%) for CMSA is below the current ROIC(3.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.66%
ROE 11.6%
ROIC 3.74%
ROA(3y)2.68%
ROA(5y)3.07%
ROE(3y)11.76%
ROE(5y)13.48%
ROIC(3y)3.5%
ROIC(5y)3.46%
CMSA Yearly ROA, ROE, ROICCMSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With a decent Profit Margin value of 12.43%, CMSA is doing good in the industry, outperforming 65.38% of the companies in the same industry.
  • CMSA's Profit Margin has improved in the last couple of years.
  • The Operating Margin of CMSA (20.22%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CMSA has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 69.45%, CMSA is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
  • CMSA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.22%
PM (TTM) 12.43%
GM 69.45%
OM growth 3Y12.41%
OM growth 5Y-0.16%
PM growth 3Y8.9%
PM growth 5Y1.91%
GM growth 3Y3.81%
GM growth 5Y0.4%
CMSA Yearly Profit, Operating, Gross MarginsCMSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1

2. CMSA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CMSA is destroying value.
  • Compared to 1 year ago, CMSA has more shares outstanding
  • The number of shares outstanding for CMSA has been increased compared to 5 years ago.
  • Compared to 1 year ago, CMSA has a worse debt to assets ratio.
CMSA Yearly Shares OutstandingCMSA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CMSA Yearly Total Debt VS Total AssetsCMSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 0.57, we must say that CMSA is in the distress zone and has some risk of bankruptcy.
  • CMSA has a Altman-Z score of 0.57. This is amonst the worse of the industry: CMSA underperforms 88.46% of its industry peers.
  • CMSA has a Debt/Equity ratio of 1.96. This is a high value indicating a heavy dependency on external financing.
  • CMSA's Debt to Equity ratio of 1.96 is on the low side compared to the rest of the industry. CMSA is outperformed by 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Altman-Z 0.57
ROIC/WACC0.77
WACC4.85%
CMSA Yearly LT Debt VS Equity VS FCFCMSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

2.3 Liquidity

  • CMSA has a Current Ratio of 0.98. This is a bad value and indicates that CMSA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CMSA has a Current ratio of 0.98. This is in the better half of the industry: CMSA outperforms 76.92% of its industry peers.
  • CMSA has a Quick Ratio of 0.98. This is a bad value and indicates that CMSA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CMSA's Quick ratio of 0.76 is fine compared to the rest of the industry. CMSA outperforms 65.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.76
CMSA Yearly Current Assets VS Current LiabilitesCMSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

5

3. CMSA Growth Analysis

3.1 Past

  • CMSA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.78%.
  • CMSA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.08% yearly.
  • Looking at the last year, CMSA shows a quite strong growth in Revenue. The Revenue has grown by 13.63% in the last year.
  • The Revenue has been growing slightly by 5.03% on average over the past years.
EPS 1Y (TTM)7.78%
EPS 3Y7.6%
EPS 5Y6.08%
EPS Q2Q%8.05%
Revenue 1Y (TTM)13.63%
Revenue growth 3Y-0.22%
Revenue growth 5Y5.03%
Sales Q2Q%12.27%

3.2 Future

  • CMSA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.02% yearly.
  • CMSA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.47% yearly.
EPS Next Y8.77%
EPS Next 2Y8.3%
EPS Next 3Y8.12%
EPS Next 5Y8.02%
Revenue Next Year6.78%
Revenue Next 2Y5.72%
Revenue Next 3Y5.22%
Revenue Next 5Y6.47%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMSA Yearly Revenue VS EstimatesCMSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
CMSA Yearly EPS VS EstimatesCMSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3 4 5

7

4. CMSA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 5.94, the valuation of CMSA can be described as very cheap.
  • 80.77% of the companies in the same industry are more expensive than CMSA, based on the Price/Earnings ratio.
  • CMSA is valuated cheaply when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 5.47, the valuation of CMSA can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, CMSA is valued cheaper than 80.77% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CMSA to the average of the S&P500 Index (22.19), we can say CMSA is valued rather cheaply.
Industry RankSector Rank
PE 5.94
Fwd PE 5.47
CMSA Price Earnings VS Forward Price EarningsCMSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CMSA is valued cheaper than 80.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.22
CMSA Per share dataCMSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CMSA may justify a higher PE ratio.
PEG (NY)0.68
PEG (5Y)0.98
EPS Next 2Y8.3%
EPS Next 3Y8.12%

5

5. CMSA Dividend Analysis

5.1 Amount

  • CMSA has a Yearly Dividend Yield of 2.99%.
  • Compared to an average industry Dividend Yield of 3.44, CMSA is paying slightly less dividend.
  • CMSA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.99%

5.2 History

  • On average, the dividend of CMSA grows each year by 6.09%, which is quite nice.
  • CMSA has been paying a dividend for over 5 years, so it has already some track record.
  • CMSA has decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.09%
Div Incr Years0
Div Non Decr Years2
CMSA Yearly Dividends per shareCMSA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 62.49% of the earnings are spent on dividend by CMSA. This is not a sustainable payout ratio.
  • The dividend of CMSA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.49%
EPS Next 2Y8.3%
EPS Next 3Y8.12%
CMSA Yearly Income VS Free CF VS DividendCMSA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B -1.5B
CMSA Dividend Payout.CMSA Dividend Payout, showing the Payout Ratio.CMSA Dividend Payout.PayoutRetained Earnings

CMSA Fundamentals: All Metrics, Ratios and Statistics

CMS ENERGY CORP - CMS 5 5/8 03/15/2078

NYSE:CMSA (3/27/2026, 8:08:51 PM)

21.4

-0.15 (-0.71%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)02-05
Earnings (Next)04-23
Inst Owners98.14%
Inst Owner ChangeN/A
Ins Owners0.59%
Ins Owner ChangeN/A
Market Cap6.56B
Revenue(TTM)8.54B
Net Income(TTM)1.06B
Analysts75.24
Price Target24.3 (13.55%)
Short Float %0%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield 2.99%
Yearly Dividend2.19
Dividend Growth(5Y)6.09%
DP62.49%
Div Incr Years0
Div Non Decr Years2
Ex-Date02-27
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.85%
Min EPS beat(2)-1.18%
Max EPS beat(2)8.88%
EPS beat(4)2
Avg EPS beat(4)2.35%
Min EPS beat(4)-1.18%
Max EPS beat(4)8.88%
EPS beat(8)5
Avg EPS beat(8)2.8%
EPS beat(12)6
Avg EPS beat(12)1.5%
EPS beat(16)10
Avg EPS beat(16)5.18%
Revenue beat(2)2
Avg Revenue beat(2)12.91%
Min Revenue beat(2)8.42%
Max Revenue beat(2)17.4%
Revenue beat(4)4
Avg Revenue beat(4)9.71%
Min Revenue beat(4)4.73%
Max Revenue beat(4)17.4%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)5
Avg Revenue beat(12)-6.02%
Revenue beat(16)9
Avg Revenue beat(16)0.64%
PT rev (1m)-5.22%
PT rev (3m)-3.99%
EPS NQ rev (1m)2.11%
EPS NQ rev (3m)1.8%
EPS NY rev (1m)0.56%
EPS NY rev (3m)0.59%
Revenue NQ rev (1m)0.86%
Revenue NQ rev (3m)0.78%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)2.54%
Valuation
Industry RankSector Rank
PE 5.94
Fwd PE 5.47
P/S 0.77
P/FCF N/A
P/OCF 2.93
P/B 0.72
P/tB 0.72
EV/EBITDA 8.22
EPS(TTM)3.6
EY16.82%
EPS(NY)3.92
Fwd EY18.3%
FCF(TTM)-5.19
FCFYN/A
OCF(TTM)7.29
OCFY34.08%
SpS27.87
BVpS29.84
TBVpS29.84
PEG (NY)0.68
PEG (5Y)0.98
Graham Number49.16
Profitability
Industry RankSector Rank
ROA 2.66%
ROE 11.6%
ROCE 4.75%
ROIC 3.74%
ROICexc 3.79%
ROICexgc 3.79%
OM 20.22%
PM (TTM) 12.43%
GM 69.45%
FCFM N/A
ROA(3y)2.68%
ROA(5y)3.07%
ROE(3y)11.76%
ROE(5y)13.48%
ROIC(3y)3.5%
ROIC(5y)3.46%
ROICexc(3y)3.53%
ROICexc(5y)3.49%
ROICexgc(3y)3.53%
ROICexgc(5y)3.49%
ROCE(3y)4.46%
ROCE(5y)4.4%
ROICexgc growth 3Y3.53%
ROICexgc growth 5Y-1.36%
ROICexc growth 3Y3.53%
ROICexc growth 5Y-1.36%
OM growth 3Y12.41%
OM growth 5Y-0.16%
PM growth 3Y8.9%
PM growth 5Y1.91%
GM growth 3Y3.81%
GM growth 5Y0.4%
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Debt/EBITDA 5.92
Cap/Depr 292.8%
Cap/Sales 44.78%
Interest Coverage 2.33
Cash Conversion 73.69%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.76
Altman-Z 0.57
F-Score5
WACC4.85%
ROIC/WACC0.77
Cap/Depr(3y)246.72%
Cap/Depr(5y)227.47%
Cap/Sales(3y)39.07%
Cap/Sales(5y)34.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.78%
EPS 3Y7.6%
EPS 5Y6.08%
EPS Q2Q%8.05%
EPS Next Y8.77%
EPS Next 2Y8.3%
EPS Next 3Y8.12%
EPS Next 5Y8.02%
Revenue 1Y (TTM)13.63%
Revenue growth 3Y-0.22%
Revenue growth 5Y5.03%
Sales Q2Q%12.27%
Revenue Next Year6.78%
Revenue Next 2Y5.72%
Revenue Next 3Y5.22%
Revenue Next 5Y6.47%
EBIT growth 1Y16.14%
EBIT growth 3Y12.16%
EBIT growth 5Y4.86%
EBIT Next Year87.74%
EBIT Next 3Y30.77%
EBIT Next 5Y22.98%
FCF growth 1Y-145.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.7%
OCF growth 3Y37.75%
OCF growth 5Y11.86%

CMS ENERGY CORP - CMS 5 5/8 03/15/2078 / CMSA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CMS ENERGY CORP - CMS 5 5/8 03/15/2078 (CMSA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CMSA.


What is the valuation status for CMSA stock?

ChartMill assigns a valuation rating of 7 / 10 to CMS ENERGY CORP - CMS 5 5/8 03/15/2078 (CMSA). This can be considered as Undervalued.


How profitable is CMS ENERGY CORP - CMS 5 5/8 03/15/2078 (CMSA) stock?

CMS ENERGY CORP - CMS 5 5/8 03/15/2078 (CMSA) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CMSA stock?

The Price/Earnings (PE) ratio for CMS ENERGY CORP - CMS 5 5/8 03/15/2078 (CMSA) is 5.94 and the Price/Book (PB) ratio is 0.72.


What is the financial health of CMS ENERGY CORP - CMS 5 5/8 03/15/2078 (CMSA) stock?

The financial health rating of CMS ENERGY CORP - CMS 5 5/8 03/15/2078 (CMSA) is 1 / 10.